Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/21 → 12/1/24 |
Funding
- Emergent Product Development Gaithersburg, Inc ( Award # ): $1,787,896.00
Development of a rVSV-Vectored Vaccine for Lassa Virus: Nonhuman Primate Efficacy and Immunogenicity Studies
- Geisbert, Thomas (PI)
Project: Research project